AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 168 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $229,650 | -83.9% | 29,556 | -77.2% | 0.00% | -66.7% |
Q1 2023 | $1,423,485 | +1985.5% | 129,880 | +722.0% | 0.00% | – |
Q4 2022 | $68,256 | -92.0% | 15,800 | -86.1% | 0.00% | -100.0% |
Q3 2022 | $856,000 | +14.1% | 113,890 | +52.5% | 0.00% | 0.0% |
Q2 2022 | $750,000 | +131.5% | 74,674 | +185.1% | 0.00% | +200.0% |
Q1 2022 | $324,000 | -2.1% | 26,188 | +81.1% | 0.00% | 0.0% |
Q4 2021 | $331,000 | -83.6% | 14,461 | -84.2% | 0.00% | -85.7% |
Q3 2021 | $2,023,000 | +436.6% | 91,382 | +214.0% | 0.01% | +250.0% |
Q2 2021 | $377,000 | +17.1% | 29,103 | +17.4% | 0.00% | +100.0% |
Q1 2021 | $322,000 | +41.9% | 24,800 | +77.3% | 0.00% | 0.0% |
Q2 2020 | $227,000 | -20.6% | 13,987 | -29.1% | 0.00% | -50.0% |
Q1 2020 | $286,000 | -82.9% | 19,722 | -76.1% | 0.00% | -83.3% |
Q4 2019 | $1,671,000 | +3052.8% | 82,500 | +725.0% | 0.01% | – |
Q3 2019 | $53,000 | -34.6% | 10,000 | -18.9% | 0.00% | -100.0% |
Q2 2019 | $81,000 | +22.7% | 12,325 | +22.0% | 0.00% | 0.0% |
Q1 2019 | $66,000 | – | 10,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Abingworth LLP | 400,434 | $2,723,000 | 2.47% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 231,681 | $1,580,000 | 1.46% |
NEA Management Company, LLC | 4,808,483 | $32,794,000 | 1.30% |
Kazazian Asset Management, LLC | 117,056 | $798,000 | 1.08% |
Vivo Capital, LLC | 1,213,290 | $8,275,000 | 1.06% |
Polar Capital LLP | 3,312,723 | $22,593,000 | 0.24% |
Patriot Financial Group Insurance Agency, LLC | 16,850 | $115,000 | 0.08% |
MGO ONE SEVEN LLC | 11,000 | $75,000 | 0.03% |
Hudson Bay Capital Management LP | 275,000 | $1,876,000 | 0.02% |
Candriam S.C.A. | 157,500 | $1,074,000 | 0.02% |